Thomas O. Schrader

807 total citations
23 papers, 449 citations indexed

About

Thomas O. Schrader is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Thomas O. Schrader has authored 23 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Organic Chemistry, 12 papers in Molecular Biology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Thomas O. Schrader's work include Receptor Mechanisms and Signaling (4 papers), Chemical synthesis and alkaloids (4 papers) and Synthesis and Reactivity of Sulfur-Containing Compounds (3 papers). Thomas O. Schrader is often cited by papers focused on Receptor Mechanisms and Signaling (4 papers), Chemical synthesis and alkaloids (4 papers) and Synthesis and Reactivity of Sulfur-Containing Compounds (3 papers). Thomas O. Schrader collaborates with scholars based in United States, Germany and China. Thomas O. Schrader's co-authors include Marc L. Snapper, Kohei Shimada, Georg Nickenig, Wölfgang Steglich, Petra Schnabel, Michael Böhm, Oliver Zolk, Masaaki Takahashi, Christopher R. Kauffman and Peng Zhang and has published in prestigious journals such as Journal of the American Chemical Society, Circulation and Scientific Reports.

In The Last Decade

Thomas O. Schrader

23 papers receiving 431 citations

Peers

Countries citing papers authored by Thomas O. Schrader

Since Specialization

Citations

This map shows the geographic impact of Thomas O. Schrader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas O. Schrader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas O. Schrader more than expected).

Fields of papers citing papers by Thomas O. Schrader

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas O. Schrader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas O. Schrader. The network helps show where Thomas O. Schrader may publish in the future.

Co-authorship network of co-authors of Thomas O. Schrader

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas O. Schrader. A scholar is included among the top collaborators of Thomas O. Schrader based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas O. Schrader. Thomas O. Schrader is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Diazepine Agonists of the 5-HT_2C Receptor with Unprecedented Selectivity: Discovery of Bexicaserin (LP352) 2025 ·Journal of Medicinal Chemistry ·Albert Ren, Xiuwen Zhu, Juerg Lehmann, (unknown), Thomas O. Schrader, (unknown), (unknown), John Frazer, David J. Unett, Andrew J. Grottick, Kevin Whelan, Michael Morgan, Carleton R. Sage, Nuggehally R. Srinivas, Dewey McLin, Graeme Semple	2
2	Discovery of a brain penetrant small molecule antagonist targeting LPA1 receptors to reduce neuroinflammation and promote remyelination in multiple sclerosis 2024 ·Scientific Reports ·Michael M. Poon, (unknown), Karin J. Stebbins, (unknown), (unknown), (unknown), (unknown), Christopher Baccei, Jeffrey Roppe, Thomas O. Schrader, (unknown), Yifeng Xiong, Austin Chen, Daniel S. Lorrain	3
3	Identification and In Vivo Evaluation of Myelination Agent PIPE-3297, a Selective Kappa Opioid Receptor Agonist Devoid of β-Arrestin-2 Recruitment Efficacy 2024 ·ACS Chemical Neuroscience ·Thomas O. Schrader, (unknown), Didier Bagnol, (unknown), (unknown), Christopher Baccei, Michael M. Poon, Karin J. Stebbins, Yifeng Xiong, (unknown), Jonah R. Chan, Ari Green, Daniel S. Lorrain, Austin Chen	3
4	Discovery of PIPE-359, a Brain-Penetrant, Selective M₁ Receptor Antagonist with Robust Efficacy in Murine MOG-EAE 2020 ·ACS Medicinal Chemistry Letters ·Thomas O. Schrader, Yifeng Xiong, (unknown), (unknown), Karin J. Stebbins, (unknown), Christopher Baccei, Daniel S. Lorrain	5
5	Discovery of a lead series of potent benzodiazepine 5-HT2C receptor agonists with high selectivity in functional and binding assays 2019 ·Bioorganic & Medicinal Chemistry Letters ·Albert Ren, Xiuwen Zhu, Konrad Feichtinger, (unknown), (unknown), Thomas O. Schrader, (unknown), (unknown), (unknown), John Frazer, David J. Unett, Andrew J. Grottick, Kevin Whelan, Michael Morgan, Carleton R. Sage, Graeme Semple	3
6	Asymmetric syntheses of (R)-4-halo-6,6a,7,8,9,10-hexahydro-5H-pyrazino[1,2-a][1,n]naphthyridines, important 5-HT2C agonist precursors 2018 ·Tetrahedron Letters ·Thomas O. Schrader, Xiuwen Zhu, (unknown), Sufang Li, (unknown), Albert Ren, Chunrui Wu, Graeme Semple	4
7	Tetrahydroquinoline-based tricyclic amines as potent and selective agonists of the 5-HT2C receptor 2016 ·Bioorganic & Medicinal Chemistry Letters ·Thomas O. Schrader, (unknown), Albert Ren, Konrad Feichtinger, (unknown), (unknown), Chunrui Wu, (unknown), (unknown), Joel Gatlin, (unknown), (unknown), Kevin Whelan, Carleton R. Sage, Andrew J. Grottick, Graeme Semple	6
8	Complementary asymmetric routes to fused tricyclic (R)-2,3,4,4a,5,6-hexahydro-1H-pyrazino[1,2-a]quinolines and (R)-1,2,3,4,5,5a,6,7-octahydro-[1,4]diazepino[1,2-a]quinolines 2016 ·Tetrahedron Letters ·Thomas O. Schrader, (unknown), Qi Sun, Chunrui Wu, Albert Ren, Graeme Semple	4
9	Design and synthesis of new tricyclic indoles as potent modulators of the S1P1 receptor 2014 ·Bioorganic & Medicinal Chemistry Letters ·Daniel J. Buzard, Thomas O. Schrader, Xiuwen Zhu, Juerg Lehmann, (unknown), (unknown), Sun Hee Kim, Andrew M. Kawasaki, (unknown), (unknown), Sangdon Han, Yinghong Gao, Jeff Edwards, (unknown), Jayant Thatte, Joel Gatlin, Robert M. Jones	13
10	Complementary Asymmetric Routes to (R)-2-(7-Hydroxy-2,3-dihydro-1H-pyrrolo[1,2-a]indol-1-yl)acetate 2012 ·Organic Letters ·Thomas O. Schrader, Benjamin Johnson, (unknown), (unknown), Tawfik Gharbaoui, Dipanjan Sengupta, Daniel J. Buzard, Christine Basmadjian, Robert M. Jones	31
11	Potent tricyclic pyrazole tetrazole agonists of the nicotinic acid receptor (GPR109a) 2010 ·Bioorganic & Medicinal Chemistry Letters ·P. Douglas Boatman, Thomas O. Schrader, (unknown), Benjamin Johnson, Philip J. Skinner, Jae‐Kyu Jung, (unknown), (unknown), Peter J. Webb, Graeme Semple, Carleton R. Sage, Jens Knudsen, Ruoping Chen, Andrew K.P. Taggart, Ester Carballo‐Jane, Jeremy G. Richman	23
12	GPR109a agonists. Part 2: Pyrazole-acids as agonists of the human orphan G-protein coupled receptor GPR109a 2010 ·Bioorganic & Medicinal Chemistry Letters ·Jason E. Imbriglio, (unknown), Rui Liang, Subharekha Raghavan, Darby Schmidt, (unknown), (unknown), Thomas O. Schrader, Jae‐Kyu Jung, Craig K. Esser, Tom G. Holt, (unknown), Andrew K.P. Taggart, Kang Cheng, Ester Carballo‐Jane, M. Gerard Waters, James R. Tata, Steven L. Colletti	10
13	GPR109a agonists. Part 1: 5-Alkyl and 5-aryl-pyrazole–tetrazoles as agonists of the human orphan G-protein coupled receptor GPR109a 2009 ·Bioorganic & Medicinal Chemistry Letters ·Jason E. Imbriglio, (unknown), Rui Liang, Subharekha Raghavan, Darby Schmidt, (unknown), (unknown), Thomas O. Schrader, Jae‐Kyu Jung, Craig K. Esser, Andrew K.P. Taggart, Kang Cheng, Ester Carballo‐Jane, M. Gerard Waters, James R. Tata, Steven L. Colletti	13
14	Synthesis of Isoprostanyl Phosphatidylcholine and Isoprostanyl Phosphatidylethanolamine 2006 ·The Journal of Organic Chemistry ·(unknown), Thomas O. Schrader, Marc L. Snapper	11
15	(PCy3)2Cl2RuCHPh Catalyzed Kharasch additions. Application in a formal olefin carbonylation 2004 ·Tetrahedron ·(unknown), Thomas O. Schrader, Belén Martı́n-Matute, Christopher R. Kauffman, Peng Zhang, Marc L. Snapper	46
16	Towards Synthetic Adrenaline Receptors—Shape-Selective Adrenaline Recognition in Water Towards Synthetic Adrenaline Receptors, Part V. For Part IV, see: ref. [29]. 2002 ·Chemistry - A European Journal ·(unknown), Oliver Molt, Thomas O. Schrader	2
17	Ring opening metathesis approach to the isoprostanes 2000 ·Tetrahedron Letters ·Thomas O. Schrader, Marc L. Snapper	19
18	Expression of Endothelin-1, Endothelin-Converting Enzyme, and Endothelin Receptors in Chronic Heart Failure 1999 ·Circulation ·Oliver Zolk, (unknown), (unknown), Thomas O. Schrader, Georg Nickenig, Petra Schnabel, Kohei Shimada, Masaaki Takahashi, Michael Böhm	160
19	Phosphoranaloge von Aminosäuren IV.¹Synthesen ungewöhnlicher 1-Aminophosphonsäuren über Diels-Alder-Reaktionen von (N-Acyliminomethyl)phosphonsäurediethylestern 1990 ·Synthesis ·Thomas O. Schrader, Wölfgang Steglich	9
20	Synthese von 1-Aminophosphonsäure-Derivaten über Acyliminophosphonsäure-Ester 1986 ·Synthesis ·Thomas O. Schrader, (unknown), Wölfgang Steglich	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact